Format

Send to

Choose Destination
Vaccine. 2007 Aug 14;25(33):6245-56. Epub 2007 Jun 21.

Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands.

Author information

1
Laboratory for Infectious Diseases and Perinatal Screening, RIVM, Bilthoven, The Netherlands. hein.boot@rivm.nl

Abstract

A persistent infection with human papillomavirus (HPV) is a prerequisite for the development of cervical cancer. Clinical trials with HPV-vaccines have been very successful in preventing persistent HPV16/18 infections, the two most oncogenic HPV-genotypes. We assessed the introduction of universal HPV-vaccination for preadolescent girls in the Dutch National Immunization Programme. Long-term vaccine efficacy, the need and extent of a catch-up programme for young women, and the impact of vaccination on the cervical cancer screening programme are major unresolved issues. Preliminary conservative estimates (80% vaccine efficacy and no effects on the screening programme, transmission rate, non-cervical cancer incidence, and cross protection) predict an acceptable cost-effectiveness ratio for universal vaccination of preadolescent girls.

PMID:
17630049
DOI:
10.1016/j.vaccine.2007.05.061
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center